CRC cell lines representing genotypes common in colon adenomas and carcinomas, including mutations in KRAS, APC, FAM123B, FBXW7, MSH2, PIK3CA, SMAD4, and TP53 were tested for their response to MTDIA and AG-270 combination treatment. This evidence concerns the gene MSH2 and colorectal carcinoma.